Cited by 30Hair Growth and DisordersProstate Cancer Treatment and ResearchSperm and Testicular Function

Prostaglandin D2-Mediated DP2 and AKT Signal Regulate the Activation of Androgen Receptors in Human Dermal Papilla Cells

Open access
Jeong, Kwan, Jung, Ji, Kim, Jung, Kang, Hoon·2018·International Journal of Molecular Sciences

Abstract

Prostaglandin D2 (PGD2) and prostaglandin D2 receptor 2 (DP2) is known to be an important factor in androgenetic alopecia (AGA). However, the effect of PGD2 in human dermal papilla cells (hDPCs) is not fully understood. The function of PGD2-induced expression of the androgen receptor (AR), DP2, and AKT (protein kinase B) signal were examined by using real time-PCR (qRT-PCR), western blot analysis, immunocytochemistry (ICC), and siRNA transfection system. PGD2 stimulated AR expression and AKT signaling through DP2. PGD2 stimulated AR related factors (transforming growth factor beta 1 (TGFβ1), Creb, lymphoid enhancer binding factor 1 (LEF1), and insulin-like growth factor 1, (IGF-1)) and AKT signaling (GSK3β and Creb) on the AR expression in hDPCs. However, these factors were down-regulated by DP2 antagonist (TM30089) and AKT inhibitor (LY294002) as well as DP2 knockdown in hDPCs decreased AR expression and AKT signaling. Finally, we confirmed that PGD2 stimulates the expression of AR related target genes, and that AKT and its downstream substrates are involved in AR expression on hDPCs. Taken together, our data suggest that PGD2 promotes AR and AKT signal via DP2 in hDPCs, thus, PGD2 and DP2 signal plays a critical role in AR expression. These findings support the additional explanation for the development of AGA involving PGD2-DP2 in hDPCs.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms19020556

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Other prostaglandin synthases in the same family as PTGES3 have been implicated in the production of androgens.

    “other prostaglandin synthases in the same family as PTGES3 have been implicated in the production of androgens48,49.”

    From Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer (2025) · cites this paper as [49]

    The Introduction identifies PTGDS as a prostaglandin synthase, and the Conclusions link its product, PGD2, to androgen-receptor activity in human dermal papilla cells. Neither passage says PTGDS produces androgens; the Introduction instead says androgens can stimulate PTGDS. The copy also does not establish PTGDS’s family relationship to PTGES3. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • PTGES3 protein is reported to have several protein functions and to be localized to both the cytosol and nucleus.

    “PTGES3 protein is reported to have several protein functions and to be localized to both the cytosol and nucleus41–49 (Fig. 3f).”

    From Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer (2025) · cites this paper as [49]

    The Introduction and Discussion address PTGDS, PGD2, and androgen-receptor signaling, but do not address PTGES3 protein functions or its cellular localization. Searches for PTGES3, cytosol/nucleus localization, and prostaglandin E synthase 3 found no relevant passage in our copy; page numbers were unavailable. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jeong, K., Jung, J., Kim, J., & Kang, H.
Affiliations
St. Paul's Hospital (KR)
Corresponding author
Kang, Hoon
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2018-02-12
Volume
19
Issue
2
Pages
556
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2791100636
Cited by
30
References
37
Citations by year
2026: 2 · 2025: 5 · 2024: 1 · 2023: 4 · 2022: 7 · 2021: 5 · 2019: 4 · 2018: 1
FWCI
3.34
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
This research was supported by the Ministry of Trade, Industry & Energy (MOTIE), Korea Institute for Advancement of Technology (KIAT) through the Encouragement Program for The Industries of Economic Cooperation Region (R0005754)
Topics
  • Health Sciences › Medicine › Urology › Hair Growth and Disorders
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
  • Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
Keywords
prostaglandin D2, DP2 receptor, Akt signaling, androgen receptor, dermal papilla cells, androgenetic alopecia, hair follicle, TGF-β1, CREB, GSK3β, insulin-like growth factor I, LY294002
MeSH terms
Glycogen Synthase Kinase 3 beta, Cells, Cultured, Female, Humans, Insulin-Like Growth Factor I, Middle Aged, Receptors, Androgen, Receptors, Immunologic, Receptors, Prostaglandin, Prostaglandin D2, Signal Transduction, Cyclic AMP Response Element-Binding Protein, Hair Follicle, Dermis, Proto-Oncogene Proteins c-akt, Lymphoid Enhancer-Binding Factor 1, Transforming Growth Factor beta1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review